NCT00088543: Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant |
|
|
| Completed | N/A | 60 | US, Canada | Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)] | Genzyme, a Sanofi Company | Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Graft vs. Host Disease (GvHD) | 04/06 | 04/06 | | |
